SREBF1 and metabolic dysfunction-associated steatotic liver disease: Several studies have demonstrated that omega-6 and omega-3 fatty acids suppress lipogenesis and NAFLD development by inhibiting SREBP1c and transcriptional genes involved in lipogenesis [13, 38–42].